Información del artículo
El Texto completo está disponible en PDF
Bibliografía
[1.]
V. Ortiz, D. Nicolás, M.A. Pastor, V. Olaso, J. Berenguer.
Síndrome carcinoide: avances en diagnóstico y tratamiento.
Rev Esp Enferm Dig, 91 (1999), pp. 61-69
[2.]
M.E. Caplin, J.R. Buscombe, A.J. Hilson, A.L. Jones, A.F. Watkinson, A.K. Burroughs.
Carcinoid tumour.
Lancet, 352 (1998), pp. 799-805
[3.]
M.E. Caplin, H.J. Hodgson, A.P. Dhillon, R. Begent, J. Buscombe, R. Dick, et al.
Multimodality treatment for gastric carcinoid tumor with liver metastases.
Am J Gastroenterol, 93 (1998), pp. 1945-1948
[4.]
W. Creutzfeldt.
Historical background and natural history of carcinoids.
Digestion, 55 (1994), pp. 3-10
[5.]
A. Sandor, I.M. Modlin.
A retrospective analysis of 1570 appendiceal carcinoids.
Am J Gastroenterol, 93 (1998), pp. 422-428
[6.]
J.A. Norton.
Surgical management of carcinoid tumors: role of debulking and surgery for patients with advanced disease.
Digestion, 55 (1994), pp. 98-103
[7.]
A.G. Harris, J.S. Redfern.
Octreotide treatment of carcinoid syndrome: analysis of published dose-titration data.
Aliment Pharmacol Ther, 9 (1995), pp. 387-394
[8.]
M.H. Kulke, R.J. Mayer.
Carcinoid tumors.
N Engl J Med, 340 (1999), pp. 858-868
[9.]
P.C. Neary, P.H. Redmond, T. Houghton, G.R.K. Watson, D. Bouchier-Hayes.
Carcinoid disease. Review of the literature.
Dis Colon Rectum, 40 (1997), pp. 349-362
[10.]
C.J. Gilligan, G.P. Lawton, L.H. Tang, A.B. West, I.M. Modlin.
Gastric carcinoid tumors: the biology and therapy of an enigmatic and controversial lesion.
Am J Gastroenterol, 90 (1995), pp. 338-352
[11.]
M.A. Memon, H. Nelson.
Gastrointestinal carcinoid tumors. Current management strategies.
Dis Colon Rectum, 40 (1997), pp. 1101-1118
[12.]
D. Granberg, E. Wilander, M. Stridsberg, G. Granerus, B. Skogseid, K. Öberg.
Clinical symptoms, hormone profiles, treatment, and prognosis in patients with gastric carcinoids.
Gut, 43 (1998), pp. 223-228
[13.]
P. Tomassetti, M. Migliori, G.C. Caletti, P. Fusaroli, R. Corinaldesi, L. Gullo.
Treatment of type II gastric carcinoid tumors with somatostatin analogues.
N Engl J Med, 343 (2000), pp. 551-554
[14.]
H. Ahlman, L. Kölby, L. Lundell, L. Olbe, B. Wängberg, G. Granérus, et al.
Clinical management of gastric carcinoid tumors.
Digestion, 55 (1994), pp. 77-85
[15.]
I.M. Modlin, C.J. Gilligan, G.P. Lawton, L.H. Tang, A.B. West, U. Darr.
Gastric carcinoids. The yale experience.
Arch Surg, 130 (1995), pp. 250-255
[16.]
S. Rappel, A. Altendorf-Hofmann, M. Stolte.
Prognosis of gastric carcinoid tumours.
Digestion, 56 (1995), pp. 455-462
[17.]
B.I. Hirschowitz, J. Griffith, D. Pellegrin, O.W. Cummings.
Rapid regression of enterochromaffinlike cell gastric carcinoids in pernicious anemia after antrectomy.
Gastroenterology, 102 (1992), pp. 1409-1418
[18.]
M. Rothmund, O. Kisker.
Surgical treatment of carcinoid tumors of the small bowel, appendix, colon and rectum.
Digestion, 55 (1994), pp. 86-91
[19.]
A. Roggo, W.C. Wood, L.W. Ottinger.
Carcinoid tumors of the appendix.
Ann Surg, 217 (1993), pp. 385-390
[20.]
S.J. Connor, G.B. Hanna, F.A. Frizelle.
Retrospective clinicopathologic anaysis of appendiceal tumors from 7970 appendectomies.
Dis Colon Rectum, 41 (1998), pp. 75-80
[21.]
P. Sauven, J.A. Ridge, S.H. Quan, E.R. Sigurdson.
Anorectal carcinoid tumors.
Ann Surg, 211 (1990), pp. 67-71
[22.]
K. Matsui, T. Iwase, M. Kitagawa.
Small, polypoid-appearing carcinoid tumors of the rectum: clinicopathologic study of 16 cases and effectiveness of endoscopic treatment.
Am J Gastroenterol, 85 (1993), pp. 1949-1953
[23.]
Y. Imada-Shirakata, M. Sakai, T. Kajiyama, G. Kin, K. Inoue, A. Torii, et al.
Endoscopic resection of rectal carcinoid tumors using aspiration lumpectomy.
Endoscopy, 28 (1996), pp. 34-38
[24.]
S. Higaki, M. Nishiaki, N. Mitani, H. Yanai, M. Tada, K. Okita.
Effectiveness of local endoscopic resection of rectal carcinoid tumors.
Endoscopy, 29 (1997), pp. 171-175
[25.]
A.B. Jetmore, J.E. Ray, J.B. Gathright, K.M. McMullen, T.C. Hicks, A.E. Timmcke.
Rectal carcinoids: the most frequent carcinoid tumor.
Dis Colon Rectum, 35 (1992), pp. 717-725
[26.]
A.N. Koura, G.G. Glacco, S.A. Curley, J.M. Skibber, B.W. Feig, L.M. Ellis.
Carcinoid tumors of the rectum. Effect of size, histopathology, and surgical treatment on metastasis free survival.
Cancer, 79 (1997), pp. 1294-1298
[27.]
K. Shirouzu, H. Isomoto, T. Kakegawa.
Treatment of rectal carcinoid tumors.
Am J Surg, 160 (1990), pp. 262-265
[28.]
H. Ishikawa, K. Imanishi, S. Otani, M. Tatsuta, S. Ishiguro.
Effectiveness of endoscopic treatament of carcinoid tumors of the rectum.
Endoscopy, 21 (1989), pp. 133-135
[29.]
T. Matsumoto, M. Iida, H. Suekane, M. Tominaga, T. Yao, M. Fujishima.
Endoscopic ultrasonograpy in rectal carcinoid tumors: contribution to selection of therapy.
Gastrointest Endosc, 37 (1991), pp. 539-542
[30.]
M. Gregor.
Therapeutic principles in the management of metastasising carcinoid tumors: drugs for symptomatic treatment.
Digestion, 55 (1994), pp. 60-63
[31.]
K. Öberg, B. Erikson.
The role of interferons in the management of carcinoid tumours.
Br J Haematol, 79 (1991), pp. 74-79
[32.]
S.B. Saslow, J.S. Scolapio, M. Camilleri, S. Forstrom, G.M. Thomforde, D.D. Burton, et al.
Medium term effects of a new 5HT3 antagonist, alosetron, in patients with carcinoid diarrhoea.
Gut, 42 (1998), pp. 628-634
[33.]
S. Halford, J. Waxman.
The management of carcinoid tumours.
Q J Med, 91 (1998), pp. 795-798
[34.]
A. Pazos, I. Mediadores celulares.
Histamina y 5-hidroxitriptamina. Farmacología de la migraña.
Farmacología humana. 3.a ed, pp. p305-p325
[35.]
H. Schwörer, Münke, F. Stöckmann, G. Ramador.
Treatment of diarrhea in carcinoid syndrome with ondansetron, tropisetron and clonidine.
Am J Gastroenterol, 90 (1995), pp. 645-648
[36.]
R. Arnol, M.E. Trautmann, W. Creutzfeldt, R. Benning, M. Bennig, C. Neuhaus, et al.
Somatostatin analogue octreotide and inhibition of tumour growth in metastatic endocrine gastroenteropancreatic tumours.
Gut, 38 (1996), pp. 430-438
[37.]
M. Di Bartolomeo, E. Bajetta, R. Buzzoni, L. Mariani, C. Carnaghi, L. Somma, et al.
Clinical efficacy of octreotide in the treatment of metastatic neuroendocrine tumors.
Cancer, 77 (1996), pp. 402-408
[38.]
R. Arnold, M. Frank, U. Kajdan.
Management of gastroenteropancreatic endocrine tumors: the place of somatostatin analogues.
Digestion, 55 (1994), pp. 107-113
[39.]
K. Öberg, B. Erikson, E.T. Janson.
Interferons alone or in combination with chemotherapy or other biologicals in the treatment of neuroendocrine gut and pancreatic tumors.
Digestion, 55 (1994), pp. 64-69
[40.]
M. Frank, K.J. Klose, M. Wied, N. Ishaque, C. Schade-Brittinger, R. Arnol.
Combination therapy with octreotide and alpha-interferon: effect on tumor growth in metastatic endocrine gastroenteropancreatic tumors.
Am J Gastroenterol, 94 (1999), pp. 1381-1387
[41.]
P. Ruszniewskj, M. Ducreux, J.A. Chayvialle, J. Blumberg, D. Cloarec, H. Michel, et al.
Treatment of the carcinoid syndrome with the long acting somatostatin analogue lanreotide: a prospective study in 39 patients.
Gut, 39 (1996), pp. 279-283
[42.]
P. Tomassetti, M. Migliori, L. Gullo.
Slow-release lanreotide treatment in endocrine gastrointestinal tumors.
Am J Gastroenterol, 93 (1998), pp. 1468-1471
[43.]
G.P. McEntee, D.M. Nagorney, L.K. Kvols, C.G. Moertel, C.S. Grant.
Cytoreductive hepatic surgery for neuroendocrine tumors.
Surgery, 108 (1990), pp. 1091-1096
[44.]
H. Ahlman.
The role of surgery in patients with advanced midgut carcinoid tumours.
Digestion, (1996), pp. 86-87
[45.]
M.E. Clouse, L. Perry, K. Stuart, K.R. Stokes.
Hepatic arterial chemoembolization for metastatic neuroendocrine tumors.
Digestion, 55 (1994), pp. 92-97
[46.]
T. Casanovas.
Trasplante hepático en los tumores primitivos y metastásicos del hígado exceptuando el hepatocarcinoma.
Gastroenterol Hepatol, 24 (2001), pp. 75-78
[47.]
A. Frilling, X. Rogiers, W.T. Knöfel, C.E. Broelsch.
Liver transplantation for metastatic carcinoid tumors.
Digestion, 55 (1994), pp. 104-106
[48.]
A. Chakravarthy, R.A. Abrams.
Radiation therapy in the management of patients with malignant carcinoid tumors.
Cancer, 75 (1995), pp. 1386-1390
[49.]
M.B. Jacobsen, L.E. Hanssen, R. Kolmannskog, E. Schrumpf, M.H. Vain, A. Bergan.
Interferon-alpha-2b, with or without prior hepatic artery embolization: clinical response and survival in midgut carcinoid patients. The Norwegian carcinoid study.
Scand J Gastroenterol, 30 (1995), pp. 789-796
Copyright © 2002. Elsevier España, S.L.. Todos los derechos reservados
